Skip to main content
Fig. 1 | BMC Musculoskeletal Disorders

Fig. 1

From: Bone marrow aspirate concentrate versus platelet-rich plasma for treating knee osteoarthritis: a one-year non-randomized retrospective comparative study

Fig. 1

Evolution of VAS scores in BMAC and PRP groups. Changes (%) in VAS scores from baseline are represented as mean ± 95% CI. A general linear model for repeated measures was used to calculate p-values within each group compared to baseline and between treatment groups. BMAC, bone marrow aspirate concentrate; CI, confidence interval; ns, nonsignificant; PRP, platelet-rich plasma; Ref, reference

Back to article page